Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

245 results about "Ferrous Fumarate" patented technology

This medication is an iron supplement used to treat or prevent low blood levels of iron (e.g., for anemia or during pregnancy).

Ammonium polyphosphate solutions containing multi-functional phosphonate corrosion inhibitors

A corrosion-inhibited fire retardant composition is provided that comprises at least one ammonium polyphosphate, at least one suspending agent, at least one phosphonate selected from a group consisting of aminotri(methylenephosphonic acid), 1-hydroxyethylidene-1,1-diphosphonic acid, hexamethylenediaminetetra(methylenephosphonic acid), diethylenetriaminepenta(methylenephosphonic acid), salts thereof, and mixtures thereof and a corrosion inhibiting system. The corrosion inhibiting system is comprised of at least one corrosion inhibiting compound selected from a group consisting of azoles, insoluble ferric pyrophosphate, soluble ferric pyrophosphate, ferrous oxalate, ferric citrate, ferrous sulfate, ferric ammonium citrate, insoluble ferric orthophosphate, soluble ferric orthophosphate, ferric ammonium oxalate, ferric ammonium sulfate, ferric bromide, ferric sodium oxalate, ferric stearate, ferric sulfate, ferrous acetate, ferrous ammonium sulfate, ferrous bromide, ferrous gluconate, ferrous iodide, ferric acetate, ferric fluoroborate, ferric hydroxide, ferric oleate, ferrous fumarate, ferrous oxalate, ferrous oxide, ferric lactate, ferric resinate, and any combination thereof. Methods of making and using the same are also described. In addition, agricultural plant nutrients comprising the same are provided.
Owner:PERIMETER SOLUTIONS LP

Extended cycle multiphasic oral contraceptive method

ActiveUS20050227952A1BiocideOrganic active ingredientsObstetricsEthinyl oestradiol
A multiphasic method of contraception that provides for sequentially administering to a female of child bearing age: (a) a Phase I composition containing a progestogen in an amount equivalent to about 0.5 to about 1.5 mg norethindrone acetate and an estrogen in an amount equivalent to about 5 to about 30 mcg of ethinyl estradiol for about 4 to about 7 days; (b) a Phase II composition containing a progestogen in an amount equivalent to about 0.5 to about 1.5 mg of norethindrone acetate and an estrogen in an amount equivalent to about 10 to about 40 mcg of ethinyl estradiol for about 8 to about 16 days; (c) a Phase III composition containing a progestogen in an amount equivalent to about 0.5 to about 1.5 mg of norethindrone acetate and an estrogen in an amount equivalent to about 5 to about 30 mcg of ethinyl estradiol for about 4 to about 7 days; and (d) optionally, a Phase IV composition which is a placebo or a non-steroidal component, such as for example, ferrous fumarate, for about 2 to about 9 days, wherein the ethinyl estradiol equivalent amount of estrogen in the Phase II composition is at least 5 mcg greater than the ethinyl estradiol equivalent amount of estrogen in each of the Phase I and III compositions. Preferably the sequential administration of the Phase I, II, and II compositions is repeated the day following the completion of the administration of the Phase III compositions to provide an extended cycle multiphasic oral contraceptive method.
Owner:APTALIS PHARMA

Preparation method of ovalbumin emulsion having double-shell structure

The invention discloses a preparation method of an ovalbumin emulsion having a double-shell structure. A purpose of the present invention is to solve the problems of to-be-improved shell-core stability and insufficient emulsifying property of the existing ovalbumin emulsion. The technical scheme comprises: (1) dissolving ovalbumin in water, carrying out magnetic stirring dissolving, adding inulin,and carrying out ultrasonic treatment to obtain an ovalbumin-inulin solution; (2) adding an oily core material to the ovalbumin-inulin solution, placing under a high-speed shearing device, shearing,and carrying out high-pressure micro-jet homogenizing a plurality of times to obtain an emulsion; (3) loading the iron ions of ferrous fumarate onto the surface of the emulsion droplet of the emulsionby using an ion exchange method to obtain a mixed solution, adjusting the pH value of the mixed solution, and carrying out centrifuging concentrating to obtain a concentrated emulsion; and (4) addingdisodium stannous citrate to the concentrated emulsion, and stirring at a low speed to obtain the ovalbumin emulsion. According to the present invention, the process is simple, the double-shell corestructure is stable, the emulsifying activity and the emulsifying stability of ovalbumin are substantially improved, and the ovalbumin emulsion has health effect, and further has good storage stability.
Owner:安徽荣达食品有限公司

Process for producing ferrous fumarate

The invention discloses a process for producing ferrous fumarate. The process flow of the process comprises the following steps of: adding water in a salt dissolving kettle, and heating the water to atemperature of between 80 and 85 DEG C; adding fumaric acid and sodium carbonate in sequence; heating the mixture obtained by the previous step to a temperature of 100 DEG C; adding the mixture obtained by the previous step and ferrous sulphate in a reaction kettle; heating the mixture obtained by the previous step to the temperature of 100 DEG C for chemical reaction; discharging the resulting product and cooling resulting product; centrifugally separating the resulting product; drying the product of the centrifugal separation; measuring and packaging the product; and obtaining finished products. Due to the process, the production is free from 'three wastes' discharge, so that the environment is protected; the ferrous fumarate content of the product manufactured by the process is as highas 91.5 percent, the iron content of the product is 30 percent, the ferrous fumarate manufactured by the process can be widely used in animal feed additives in breeding production, is high in purity,iron content and absorption rate and low in cost and high in benefit, and can contributes to the sound and fast development of the state breeding industry.
Owner:SICHUAN ANIMTECH FEED CO LTD

Konjac glucomannan aqua filter core and preparation method therefor

The invention relates to a konjac glucomannan aqua filter core and a preparation method therefor. The preparation method for the konjac glucomannan aqua filter core comprises the steps of preparing konjac fibers, preparing konjac glucomannan gel microspheres, preparing nutritional supplement containing konjac glucomannan gel microspheres and preparing the filter core. The konjac glucomannan aqua filter core disclosed by the invention adopts konjac as a main raw material and plays a role by using the adsorption performance of the konjac fibers and the konjac glucomannan gel microspheres and the sustained release performance of the microspheres. The konjac fibers can be used for purifying water, and the konjac glucomannan gel microspheres can be used for filtering out most microorganisms in the water, so that microbiocides are not required to be used to a large extent; and the nutritional supplement containing konjac glucomannan gel microspheres can enable nutrients to be released in a long-term, stable and continuous manner so as to guarantee human body absorption efficiency. A nutritional supplement contains the ingredients, i.e., calcium carbonate, ferrous fumarate, zinc sulfate, sodium selenite, copper sulfate, manganese sulfate, chromium picolinate and the like and can be used for supplementing human required essential trace elements such as calcium, ferrum, zinc, selenium, copper, manganese, chromium and the like.
Owner:FUJIAN AGRI & FORESTRY UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products